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Abstract 
Introduction: The goal of this study was to determine the frequency of bacterial isolates cultured from diabetic 
foot infections and to assess their amoxyclav resistance and susceptibility.Methods: A total of 378 diabetic foot 
lesions were included in this prospective analysis. The antibiotic susceptibility pattern of bacteria isolated from 
foot lesions was assessed using the Kirby-Bauer disk diffusion method.Results: The most commonly isolated 
Gram-positive bacteria were Staphylococcus aureus, followed by Enterococcus spp. and CoNS. The most 
commonly isolated Gram-negative bacteria were Klebsiella spp., Pseudomonas spp., Proteus spp., Escherichia coli, 
Enterobacter spp., Citrobacter spp., Citrobacter freundii, and Proteus vulgaris. Amoxyclav was found to be 100.00% 
resistant against Pseudomonas aeruginosa and followed by Enterococcus spp. (89.50%), Proteus spp. (87.50%), 
Staphylococcus aureus (84.30%), Escherichia coli (81.50%), Klebsiella spp. (70.50%) and Enterobacter spp. 
(69.20%).Conclusion: The present study confirmed the prevalence of amoxyclav drug resistant pathogens 
(84.90%) in diabetic foot ulcers. The diverse bacteria infecting the wound must be evaluated, as well as the 
antibiotic susceptibility patterns of the isolates from the infected lesion. This information is critical for selecting 
the right medications, eliminating resistance trends, and lowering healthcare costs. 
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Introduction 
Diabetes is a life-long condition. It affects many people all over the world. It is a significant public health issue 
[1]. About one-fourth of people with diabetes will develop an ulcer throughout their lifetime, and as many as half 
of those ulcers turns into infected [2, 3]. In human beings with diabetes and foot ulcers, numerous elements, such 
as inappropriate antibiotic treatment, the chronic nature of the wound, and frequent clinic admission, can have an 
effect on the presence of multidrug-resistant microorganisms inside the ulcer [4]. Moreover, the particular 
organisms  identified in diabetic foot infections can differ not only from patient to patient and hospital to hospital 
but additionally from one a part of the country to some other [5]. 
Diabetic foot is a crippling condition. It offers long stretches of hospitalization. Health center prices may be 
very excessive and now and again not possible to undergo the charges, and the end result of an amputated limb. 
The ghostly limb adds insult to injury to the already battered psyche. No surprise, one of the most feared 
complications of diabetes is diabetic foot. The classic triad of neuropathy, ischemia, and infection characterizes 
diabetic foot. The first priority should be to prevent diabetic foot. This can be accomplished by identifying high-
risk individuals, such as those who have peripheral neuropathy, peripheral vascular disease, foot deformities, or 
callu [6]. 
If not treated promptly, infectious microorganisms are linked to amputation of the infected foot, as well as an 
increase in hospital stay, cost of management, morbidity, and mortality [7]. Because most diabetic foot infections 
are true emergencies, antibiotic therapy should be initiated as soon as possible to improve the chances of saving 
the limb. Clinical presentation, gram-staining results, and knowledge of the organisms most commonly isolated 
from a specific infection should all be used to guide initial empirical therapy [8]. 
Diabetes-related foot ulcers are common and estimated to affect 15% of all diabetic individuals during their 
lifetime.  Amputation is required in 15 to 20% of patients with such foot ulcers. Almost  85% of the amputations 
are preceded by diabetic foot  ulcers [9-11]. Peripheral sensory neuropathy is the most important risk factor for the 
development of foot ulcers, followed by peripheral vascular disease. In diabetics, the proportion of neuropathic, 
neuroischemic, and purely ischemic lesions is 54, 34, and 10%, respectively [11]. It is estimated that approximately 
40,000 legs are amputated in India each year, with 75 percent of them being neuropathic with secondary infection, 
which is potentially preventable.  Barefoot walking, illiteracy, low socioeconomic status, late presentation by 
patients, primary care physician ignorance about diabetic foot care, and belief in alternative systems of medicine 
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all contribute to this high prevalence [12]. 
Infection in a diabetic foot is a limb threatening condition because the consequences of deep infection in a 
diabetic foot are more disastrous than elsewhere mainly because of certain anatomical peculiarities. The foot has 
several compartments, which are inter-communicating and the infection can spread from one into another, and 
lack of  pain allows the patient to continue ambulation further facilitating the spread. The foot also has soft tissues, 
which cannot resist infection, like plantar aponeurosis, tendons, muscle sheaths, and fascia. A combination of 
neuropathy, ischemia, and hyperglycemia worsens the situation by reducing the defense mechanism [6]. 
The correct antibiotic selection based on the antibiograms of isolates from diabetic foot infections is critical 
for the proper management of these infections. As a result, the current study sought to assess the bacteriology of 
diabetic foot ulcers at Hospital Geral de Palmas in Tocantins, Brazil, in order to determine the relative frequencies 
of bacterial isolates cultured from foot infections and to assess the isolated bacteria's in vitro antibiotic resistance 
and susceptibility to amoxyclav antibiotic. 
 
Materials and Methods 
Materials  
Study Design 
This cross-sectional study was designed to assess the bacterial profile cultured from the wounds of diabetic foot 
patients, and to assess the functional pattern of the amoxicillin antibiotic on the cultured microorganisms. 
 
Data Collection 
Laboratory data from May 2020 to May 2021 were routinely collected from the microbiology department from 





Wound beds were prepared before specimen collection, where the wound immediate surface exudates and 
contaminants were cleansed off with moistened sterile gauze and sterile normal saline solution. Dressed wounds 
were cleansed with non bacteriostatic sterile normal saline after removing the dressing. Aseptically the end of a 
sterile cotton-tipped applicator was rotated over 1 cm2 area for 5 seconds with sufficient pressure to express fluid 
and bacteria to surface from within the wound tissue [13]. The specimens were placed into sterile transport 
containers and sent to the microbiology laboratory for aerobic culturing within 20 minutes. Anaerobic culturing 
was not performed in this study [14, 15].  
 
Bacterial Culture 
Cultures were processed following the standard procedure [14, 15]. Samples were inoculated on MacConkey agar 
(Oxoid), Chocolate agar (Oxoid) and Blood agar (Oxoid) media plate under class-II laminar airflow (NUVO 
SanajiMalzemelzeni, ImalatVcTicaret A.S, Turkey). The inoculum on the plate was streaked out for discrete 
colonies with a sterile wire loop sterilized by auto loop sterilizer (Germany) following standard procedures.  The 
culture plates were incubated at 37°C by an incubator (Germany) for 48 hours and observed for the growth of 
bacteria through formation of colonies. All the bacteria were isolated and identified using morphological, 
microscopy (Japan) and biochemical tests like TSI (HiMedia), MIU (HiMedia) and Simmons Citrate (HiMedia) 
agar following standard procedures. 
 
Antibiotic Susceptibility Assessment  
The disc diffusion technique was used for antibacterial susceptibility testing of the isolates  [16-18] using 
commercial antibiotics containing discs. We used the commercial antibiotic disc. Bacterial susceptibility was 
determined by the Kirby-Bauer disc diffusion method using antibiotic containing discs from Oxoid Ltd, UK. 
Amoxyclav antibiotic discs were used in this study. Interpretation of results was analysed using zone sizes. Zones 
of inhibition ≥21mm will be considered sensitive, 16-20mm intermediate and <15 mm resistant. Isolates were 
classified as either sensitive or resistant based on the definition of the Clinical and Laboratory Standard Institute 
[17].   
 
Statistical Analysis 
Data were assessed by using the free software GNU PSPP stable release 1.4.1/ September 5, 2020. It has a graphical 
user interface and conventional command-line interface. It is written in C and uses GNU Scientific Library for its 
mathematical routines. The name has "no official acronymic expansion". Statistical frequencies were analyzed 
here. 
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A diabetic treatment center provided us with 378 participants for this research. They had all been diagnosed with 
diabetes and had diabetic feet. Males made up 247 (60.0%) of the subjects, with 165 females (40.0%) (Figure-1). 
 
Figure-1: Sex distribution of the diabetic foot patients. 
Among 378 diabetic foot subjects in the age group 10-20 years, males were 6 (1.5%) and females were 1 
(0.2%). The age group > 20-30 years showed that males were 2 (0.5%) and females were 13 (3.2%). 27 (6.6%) 
males and 17 (4.1%) females were found in the age group > 30-40 years. The age group > 40-50 years showed 
that almost equal males and females were in this area. Males were 55 (13.3%) and females were 57 (13.8%). The 
highest female subjects were found in 
 
Figure-2: Sex distribution in different age groups. 
the > 40-50 year age group. The highest peak for diabetic foot subjects went to males, 84 (20.4%) in the age 
group category > 50-60 years and in this category females were 42 (10.2%). 48 males (11.7%) and 32 females 
(7.8%) were found in the age group > 60-70 years. The age group > 70-80 years was represented by 21 males 
(5.1%) and 3 females (0.7%). age groups > 80-90 years and > 90-100 years showed no female subjects. 1 male 
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Acinatobacter spp. 11 2.91 2.91 3.17 
CONS (Staphylococcus aureus and 
Staphylococcus 
Saprophyticu) 10 2.65 2.65 5.82 
Citrobacter Freundii 4 1.06 1.06 6.88 
Citrobacter spp. 9 2.38 2.38 9.26 
Enterobacter spp. 27 7.14 7.14 16.4 
Enterococcus spp. 20 5.29 5.29 21.69 
Escherichia coli 27 7.14 7.14 28.84 
Klebsiella spp. 48 12.70 12.70 41.53 
Proteus spp. 42 11.11 11.11 52.65 
Proteus vulgaris 3 0.79 0.79 53.44 
Pseudomonas aeruginosa 8 2.12 2.12 55.56 
Pseudomonas spp. 44 11.64 11.64 67.2 
Serratia marcescens 1 0.26 0.26 67.46 
Staphylococcus aureus 123 32.54 32.54 100 
Total 378 100 100  
Among 378 diabetic foot patients (no missing data), 2.91% were infected with Acinetobacter spp., 1.06% 
were with Citrobacter freundii. 2.38% were infected with Citrobacter spp., CoNS were in 2.65% of patients. 
Enterobacter spp. was responsible for 7.14% of infections. Escherichia coli caused 7.14% of infections. 12.70% 
infection identified for Klebsiella spp. and 11.11% for Proteus spp.. Proteus vulgaris infected a small percentage 
of the patients and that was 0.79%. Pseudomonas aeruginosa was dedicated to 2.12% infection. Among all 
microorganisms, the lowest infection was found by Serratia marcescens and the infection rate was 0.26%. The 




Figure-3: Distribution of gram positive (+ ve) and gram negative (-ve) microorganisms among diabetic 
foot patients. 
Among the all microorganisms (14) highest of organisms were gram negative (10) and lowest numbers were 
gram positive (4).Acinetobacter spp. (12), Citrobacter freundii (4), Citrobacter spp. (10), Enterobacter spp. (27) 
Escherichia coli (30), Klebsiella spp. (52)   Proteus spp. (42),  Proteus vulgaris (3), Pseudomonas aeruginosa (8), 
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Figure-4: Sex distribution of gram positive (+ ve) and gram negative (-ve) microorganisms among diabetic 
foot patients. 
Figure-4 described sex distribution regarding specific microorganism. i) In respect to Acinetobacter spp. 
pattern was 3.24% for male and 2.42% for female, ii) 0.01% male was found for Citrobacter feundii iii) 2.02% of 
males and 3.03% of females were found infected with Citrobacter spp. iv) 2.43% male was found for CoNS and 
female was 3.64%. v) 7.29% male was found for Enterobacter spp. and female was found 5.45%. vi) 6.07% of 
males were infected with Enterococcus spp. and 9.09% female. vii)  Escherichia coli found in 7.29% male, female 
percentage was 7.27. viii) Male found 11.74% and 13.94% female in respect to Klebsiella spp. ix) Proteus spp. 
was found in 10.93% male and in 9.09% female. x) Proteus vulgaris was found in 0.81% of males and in 0.61% 
of females. xi) 1.62% of males were found with Pseudomonas aureginosa infection. 2.42% females were found 
with Pseudomonas aureginosa infection. xii. No female was found with Serratia marcescens and 100.00% were 
males. xiii. Staphylococcus aureus was found as a big name in our experiment. 34.41% of males were infected by 
this organism and the female percentage was 33.94. 
 
Figure-5: Amoxyclav’s functional profile. 
As a whole, we got a scenario that amoxyclav was sensitive for 15.10% of diabetic foot patients and 84.90% 
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Figure-6: Sensitivity and resistant pattern of amoxyclav against different microorganisms. 
Figure-2 described resistant and sensitivity pattern against amoxyclav. i) In respect to Acinetobacter spp. 
pattern was 0.00-100.00%, that means 0.00% was for sensitivity and 100.00% was for resistant ii) 10.00% 
sensitivity was found for Citrobacter feundii and 90.00% for resistant iii) 100.00% sensitive applied for 
Citrobacter spp. iv) 100.00% sensitivity was found for CoNS spp. v) 30.80% sensitivity and 69.20% were found 
for Enterobacter spp. vi) 10.50% resistant Enterococcus spp. was found rest 89.50% was sensitive. vii) 
Escherichia coli showed 18.50% resistance against amoxyclav, sensitivity percentage looked high (89.50%). viii) 
amoxyclav found 29.50% resistant and 70.50% sensitive against Klebsiella spp. ix) Proteus spp. was found 12.50% 
resistant and 87.50% sensitive. x) Proteus vulgaris infection, 33.30% diabetic foot infection with this organism 
showed resistance against amoxyclav and 66.70% were fine with amoxyclav. xi) 100.00% diabetic foot infection 
with this organism showed resistance against amoxyclav. xii) Serratia marcescens showed 100.00% resistant. xiii) 
Staphylococcus aureus was found as a big name in our experiment. 15.70% of this organism showed resistance 
against target antibiotic and 84.30% showed sensitive. 
 
Discussion 
Foot infections in patients with diabetes are a common, complex, and costly problem [19]. In the present study, 
we found that elderly patients (˃60 years of age) constituted the majority of patients with foot infections. This may 
be explained by the fact that foot lesions occur commonly among patients with diabetes, particularly the elderly 
and those with sensory neuropathy [20]. Previous studies have shown that the susceptibility to foot infections is 
greater in male patients than in female patients [1, 5]. However, in our study, we did not find differences between 
male and female patients, which may be because of the limited number of patients.  
Diabetic foot ulcers are colonized by pathogenic bacteria that may predispose a susceptible patient to a lower 
extremity infection, defined as the invasion and multiplication of microorganisms in body tissues associated with 
tissue destruction or host inflammatory responses [21]. In the present study, we found that the majority of lesions 
were located on the right toe and plantar region, and varied in duration from 1 day to more than 90 days. 
Additionally, recent lesions (1-30 days) were the most common. Our findings are in accordance with the results 
of Donoso et al. (2013) [22]. 
This study is limited by the fact that cultures for anaerobic bacteria could not be performed. In diabetic foot 
infections, the role of anaerobic bacteria is particularly unclear; some studies have reported that anaerobic bacteria 
play a minor role [23, 24], while other studies found a high incidence of anaerobic bacteria [5, 25]. 
The most common pathogens isolated were Gram-positive cocci, such as Staphylococcus aureus and 
Staphylococcus saprophyticus (CONS) and Gram-negative rods, such as Proteus spp. and Enterobacter spp. 












































































































Journal of Health, Medicine and Nursing                                                                                                                                          www.iiste.org 




bacteria were predominant in diabetic foot infections [25], other studies have reported that Gram-negative bacteria 
were predominant in particular regions [26, 27]. These results suggest, in part, differences in the type and severity 
of infections [5, 28]. Aerobic Gram-negative bacteria (mainly Enterobacteriaceae and sometimes Pseudomonas 
aeruginosa or other Gram-negative species) are usually isolated in conjunction with Gram-positive cocci in 
patients with chronic or previously treated infections [26], which is consistent with our findings. Polymicrobial 
infections accounted for 70% of all infections. Although polymicrobial etiology has been implicated in diabetic 
foot infections [28], a previous study reported the predominance of monomicrobial infections [28]. These 
discrepancies suggest  differences in diabetic foot infections, with severe infections usually having polymicrobial 
isolates and mild infections usually having monomicrobial isolates [28, 29]. 
 
Conclusions 
The present study report has some limitations because cultures for anaerobic bacteria could not be performed and 
sample size was small. However, it confirmed the high prevalence of multidrug-resistant pathogens in diabetic 
foot ulcers. Diabetic foot infections were predominantly due to Gram-positive bacteria, such as Staphylococcus 
aureus, or were polymicrobial infections. Many studies on the bacteriology of diabetic foot infections have 
reported results that vary and are often contradictory [25, 26, 28]. In such cases, application of molecular 
techniques may lead to more accurate microbial characterizations and targeted antibiotic therapy. Therefore, it is 
necessary to evaluate the different microorganisms infecting the wound on a routine basis and to know the 
antibiotic susceptibility patterns of the isolates from the infected wound in patients with diabetic foot lesions. This 
knowledge is crucial for planning the treatment of these patients with the appropriate antibiotics, reducing 
resistance patterns, and minimizing healthcare costs. We hope the data presented on this article can assist the 
clinicians in determining the multidrug-resistant pathogens in diabetic foot ulcers. In this study amoxyclav was 
found sensitive for 15.10% of diabetic foot patients and 84.90% of patients were found resistant. 
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